Abstract
The article is devoted to the analysis of changes in the role of causal and comorbid risk factors for two main types of heart failure with reduced and preserved ejection fraction over the previous 20 years. Within the same time interval, the dynamics of the prevalence and mortality for these clinical variants. Special attention is paid to a possible solution to the issue of the complexity of recording cases of diagnosis and treatment of chronic heart failure in outpatient and hospital practice.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference17 articles.
1. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Знакомьтесь: диастолическая сердечная недостаточность. Сердечная недостаточность. 2000;1(2):40-4 [Belenkov IuN, Ageev FT, Mareev VIu. Meet diastolic heart failure. Serdechnaia nedostatochnost'. 2000;1(2):40-4 (in Russian)].
2. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
3. CHRONIC HEART FAILURE IN RUSSIAN FEDERATION: WHAT DO WE KNOW AND WHAT TO DO
4. Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Infez Med. 2020;28(4):500-6.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献